CD4 and Alzheimer disease: Research from Ha-Jung Kim’s group shows that in the early-life of mice, intestinal microbiota can play a critical role in the development of AD by regulating the CD4+IL17+T cell/CD4+FOXP3+Treg cell balance, thereby affecting the levels of ILC3s in the gut mucosa via the modulation of SCFAs production (218).